Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: Human Laboratory Study of Apremilast for Alcohol Use Disorder [Phase 2]

View source ↗

Summary

A Phase 2 human laboratory study of apremilast for Alcohol Use Disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apremilast (apremilast)

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Alcohol Use Disorder, Alcohol Misuse | Phase 2 | Status: RECRUITING